Kimberly Claeys

39PUBLICATIONS
79CO-AUTHORS
Medical infection agents (incl. prions)Medical bacteriologyMajor global burdens of diseasePredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jun 22, 2026
Recalibration and Validation of a Risk Scoring Tool to Predict Multidrug-Resistant Pseudomonas aeruginosa.

|May 15, 2026
Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centers.

|Mar 23, 2026
Real-world use of eravacycline for the treatment of mono- and polymicrobial infections involving Enterobacterales.

Sean R Van Helden, Ashlan J Kunz Coyne, Sara Alosaimy

|Mar 13, 2026
Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients: A Pragmatic, Randomized Trial.

Jonathan D Baghdadi, Anthony D Harris, Lisa Pineles

|Oct 24, 2025
Beyond Accuracy: Methodological Advances for Assessing the Clinical Impact of Infectious Disease Diagnostics.

Kimberly C Claeys, Andrea M Prinzi, Tristan T Timbrook

|Aug 26, 2025
Eravacycline use in immunocompromised patients: multicenter evaluation of timely versus late initiation on clinical outcomes.

Ashlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas

Pageof 7

Frequent Collaborators

6 joint publications

Emily L Heil

6 joint publications

Michael J Rybak

5 joint publications

Jonathan D Baghdadi

4 joint publications

Ashlan J Kunz Coyne